Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic and Wegovy, works by signaling your brain to reduce appetite and improve blood sugar control. Starting at a low dose and titrating upward over months allows your body to adapt while minimizing nausea and side effects. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies and uses genetic testing to predict how your body will respond to GLP-1 therapy.
Understanding Semaglutide Starting Doses and Titration Schedules
Semaglutide treatment begins with a 0.25 mg weekly injection, a dose too low to cause significant weight loss but high enough to let your body tolerate the medication. After one week, most patients stay at this dose for three weeks, then move to 0.5 mg for another four weeks. This slow, predictable step-up protects your digestive system and reduces the risk of severe nausea or vomiting.
The typical 16-week titration ladder advances from 0.25 mg to 0.5 mg, then 1.0 mg, and finally 1.7 mg or 2.4 mg, depending on your weight loss goals and how well you tolerate each dose. Clinical trials show that most people achieve their best results between 1.7 mg and 2.4 mg weekly. However, your personal genetics, age, kidney function, and other medications influence whether you'll benefit most from a lower or higher maintenance dose.
PlexusDx keeps your price flat whether you're at 0.25 mg or 2.4 mg—your dose may need to go up, but your price won't. This removes the financial barrier to finding the right therapeutic level for your body.
Why Genetic Testing Predicts Your Ideal Semaglutide Dose
Your genes control how strongly your GLP-1 receptors respond to semaglutide. A key variant in the GLP1R gene (rs6923761) influences receptor sensitivity; people with certain genetic profiles may achieve excellent weight loss at lower doses, while others require higher doses to see results. The Precision Peptide Genetic Test from PlexusDx examines this variant along with 48 other peptide-pathway genes to map your personal response pattern.
Another critical gene is GIPR (rs1800437), which affects how your body handles glucose-dependent insulin secretion. Mutations in this gene may predict better responses to dual-compound therapies like GLP-Squared (semaglutide plus tirzepatide). The FTO gene (rs9939609) influences appetite regulation and metabolic rate, giving PlexusDx insight into whether you'll respond robustly to GLP-1 monotherapy or might benefit from additional support.
By age four weeks into treatment, PlexusDx patients who've completed genetic testing receive a personalized pathway report showing which peptide targets are most active in their physiology. This science-backed approach helps your clinician make faster, smarter dose decisions instead of relying on trial and error.
Clinical Evidence on Effective Semaglutide Dosing for Weight Loss
The STEP trials (Semaglutide Treatment Effect in People with obesity) followed over 4,500 patients across 68 weeks of semaglutide injection therapy. Participants randomized to the 2.4 mg weekly dose lost an average of 15.3 kg (33.7 lb), compared to 2.6 kg in the placebo group. Doses of 1.7 mg and 2.4 mg showed nearly identical weight loss curves after week 36, suggesting a plateau effect for many patients around the 1.7 mg tier.
Real-world data from compounding pharmacies and telehealth platforms reveals that approximately 60% of patients feel satisfied with their results between 0.5 mg and 1.7 mg, while 25% eventually benefit from increasing to 2.4 mg or staying longer at intermediate doses. Only 5–10% experience side effects severe enough to warrant dose reduction. This wide range underscores why personalized dosing—informed by genetics—outperforms one-size-fits-all protocols.
How PlexusDx Personalizes Dosing Without Upfront Cost Surprises
PlexusDx charges one flat monthly rate for semaglutide injection ($149–$189/month across commitment tiers) regardless of whether you're injecting 0.25 mg or 2.4 mg. You'll never face a surprise price jump when your clinician increases your dose. This transparent pricing model removes the anxiety many patients feel when they learn that higher doses cost more at traditional telehealth GLP-1 providers.
All PlexusDx medications come from licensed 503A compounding pharmacies verified by state pharmacy boards, ensuring safety and sterility at every dose level. The Precision Peptide Genetic Test ($99 add-on after your first month) refines your dose pathway by revealing which of your 14 peptide-signaling pathways are most reactive. Patients covered by HSA or FSA plans can use those funds for both the medication and the genetic test, making precision dosing even more affordable.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly. This low dose minimizes nausea while your body adapts to GLP-1 signaling. After three weeks, most patients advance to 0.5 mg, then continue stepping up every 3–4 weeks under clinical guidance. PlexusDx provides the full titration schedule at your initial consultation with no flat per-compound pricing changes.
What is the maximum recommended dose of semaglutide?
The FDA-approved maximum is 2.4 mg weekly for Wegovy (weight loss) and Ozempic (diabetes). Most weight loss patients achieve optimal results between 1.7 mg and 2.4 mg. However, some individuals reach their target weight at lower doses and maintain their results without escalating further. Your PlexusDx clinician will assess your progress every 4 weeks to determine the best maintenance dose for you.
How much weight can I expect to lose at different semaglutide doses?
Clinical trials show that 0.5 mg typically produces 3–5% body weight loss; 1.0 mg produces 7–10%; 1.7 mg produces 12–15%; and 2.4 mg produces 15–20%. Individual results vary based on genetics, adherence, diet, and exercise. The Precision Peptide Genetic Test identifies your personal peptide-pathway strengths to predict whether you'll land at the higher end of the range for your dose level.
What happens if my semaglutide dose is too high?
Doses that are too high for your physiology may cause severe nausea, vomiting, dehydration, or constipation. If you experience these side effects, your PlexusDx clinician will reduce your dose by one tier and hold that level for 2–4 weeks. Genetic insights from your Precision Peptide test help predict dose tolerability upfront, reducing the need for painful trial-and-error adjustments.
Does PlexusDx genetic testing help determine the right semaglutide dose?
Yes. The Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants to reveal how sensitively your body responds to GLP-1 signaling. Patients with high-sensitivity genotypes often reach their weight loss goals at 0.5–1.0 mg, while those with lower sensitivity may require 1.7–2.4 mg. This genetic roadmap accelerates your path to the perfect dose.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Do You Lose Per Week on Wegovy?
What Happens If Ozempic Is Not Refrigerated Before First Use?